Pharmacological agents in development for invasive aspergillosis

Jaques F.G.M. Meis; Elisabeth J. Ruijgrok

doi:10.1517/14728214.7.1.33

Pharmacological agents in development for invasive aspergillosis

Jaques F.G.M. Meis, Elisabeth J. Ruijgrok

Pharmacy

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Abstract

The urgent medical need for new potent antifungal agents in the management of invasive aspergillosis (IA) has resulted in the development of several compounds which may be of value in the future for the treatment or prophylaxis of IA. In the past years, several novel types of drugs have been discovered and developed, some of which are already in late-stage clinical trials and ready to enter the market. This paper discusses the antifungal agents, classified by their mode of action, that are currently available and the agents which are still in development for treatment or prevention of IA.

Original language	English
Pages (from-to)	33-45
Number of pages	13
Journal	Expert Opinion on Emerging Drugs
Volume	7
Issue number	1
Early online date	24 Feb 2002
DOIs	https://doi.org/10.1517/14728214.7.1.33
Publication status	Published - May 2002

Access to Document

10.1517/14728214.7.1.33

Cite this

@article{b832ff4d661d4503a969c229e09a5154,

title = "Pharmacological agents in development for invasive aspergillosis",

abstract = "The urgent medical need for new potent antifungal agents in the management of invasive aspergillosis (IA) has resulted in the development of several compounds which may be of value in the future for the treatment or prophylaxis of IA. In the past years, several novel types of drugs have been discovered and developed, some of which are already in late-stage clinical trials and ready to enter the market. This paper discusses the antifungal agents, classified by their mode of action, that are currently available and the agents which are still in development for treatment or prevention of IA.",

author = "Meis, {Jaques F.G.M.} and Ruijgrok, {Elisabeth J.}",

year = "2002",

month = may,

doi = "10.1517/14728214.7.1.33",

language = "English",

volume = "7",

pages = "33--45",

journal = "Expert Opinion on Emerging Drugs",

issn = "1472-8214",

publisher = "Taylor & Francis Ltd",

number = "1",

}

TY - JOUR

T1 - Pharmacological agents in development for invasive aspergillosis

AU - Meis, Jaques F.G.M.

AU - Ruijgrok, Elisabeth J.

PY - 2002/5

Y1 - 2002/5

N2 - The urgent medical need for new potent antifungal agents in the management of invasive aspergillosis (IA) has resulted in the development of several compounds which may be of value in the future for the treatment or prophylaxis of IA. In the past years, several novel types of drugs have been discovered and developed, some of which are already in late-stage clinical trials and ready to enter the market. This paper discusses the antifungal agents, classified by their mode of action, that are currently available and the agents which are still in development for treatment or prevention of IA.

AB - The urgent medical need for new potent antifungal agents in the management of invasive aspergillosis (IA) has resulted in the development of several compounds which may be of value in the future for the treatment or prophylaxis of IA. In the past years, several novel types of drugs have been discovered and developed, some of which are already in late-stage clinical trials and ready to enter the market. This paper discusses the antifungal agents, classified by their mode of action, that are currently available and the agents which are still in development for treatment or prevention of IA.

U2 - 10.1517/14728214.7.1.33

DO - 10.1517/14728214.7.1.33

M3 - Article

C2 - 15989534

SN - 1472-8214

VL - 7

SP - 33

EP - 45

JO - Expert Opinion on Emerging Drugs

JF - Expert Opinion on Emerging Drugs

IS - 1

ER -

Pharmacological agents in development for invasive aspergillosis

Abstract

Access to Document

Fingerprint

Cite this